Accessibility Menu
 
Gb Sciences logo

Gb Sciences

(OTC) GBLX

Current Price$0.00
Market Cap$122,100
Since IPO (2014)-100%
5 Year-100%
1 Year-57%
1 Month+0%

Gb Sciences Financials at a Glance

Market Cap

$122,100

Revenue (TTM)

$97.23K

Net Income (TTM)

$1.04M

EPS (TTM)

$-0.00

P/E Ratio

-0.12

Dividend

$0.00

Beta (Volatility)

-0.01 (Low)

Price

$0.00

Volume

100,750

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.50

GBLX News

No articles available.

GBLX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gb Sciences

Industry

Pharmaceuticals

Employees

2

CEO

Andrea Small-Howard, PhD, MBA

Headquarters

Las Vegas, NV 89118, US

GBLX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-2%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

4%

Return on Assets

-3%

Earnings Yield

-8.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$122.10K

Shares Outstanding

407.07M

Volume

100.75K

Short Interest

0.00%

Avg. Volume

98.91K

Financials (TTM)

Gross Profit

$624.00

Operating Income

$1.42M

EBITDA

$1.42M

Operating Cash Flow

$975.70K

Capital Expenditure

$0.00

Free Cash Flow

$975.70K

Cash & ST Invst.

$11.99K

Total Debt

$1.76M

Gb Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$97.23K

N/A

Gross Profit

$97.23K

N/A

Gross Margin

100.00%

N/A

Market Cap

$122.10K

N/A

Market Cap/Employee

$61.05K

N/A

Employees

2

N/A

Net Income

$100.36K

+46.3%

EBITDA

$66.44K

+55.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$1.99M

-33.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$557.00K

+642.7%

Short Term Debt

$1.44M

+0.0%

Return on Assets

-3.08%

N/A

Return on Invested Capital

4.22%

N/A

Free Cash Flow

$354.78K

-72.7%

Operating Cash Flow

$354.78K

-72.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSTCGlobeStar Therapeutics Corporation
$0.00+0.00%
IRBSIR Biosciences Holdings Inc.
$0.00+0.00%
HTDSHard to Treat Diseases Inc.
$0.00+0.00%
MOBOMobile Lads Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About GBLX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.